Carlotta L Cavazos, PA
Physician Assistant · Berkeley
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 3
- 1 carrier
- Offices
- 4
- Since medical school
- 22 years
- Graduated 2004
Offices
4 locations · UCSF Medical Group Business Services · University of California San Francisco
Hospitals listed: Alta Bates Summit Medical Center - Alta Bates Camp · UCSF Medical Center. That is not proof they admit you there this week.
Plans that list them
3 plans · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Carlotta L Cavazos’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| Imperial Courage Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Dynamic Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Senior Value (HMO C-SNP) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
Hospitals they work in
2 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Alta Bates Summit Medical Center - Alta Bates CampBerkeley, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 2 of 5 · 67% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.298, Oct 2024 – Sep 2025
- UCSF Medical CenterSan Francisco, CAAcute Care Hospital · Voluntary non-profit - Other · Has an emergency department · Birthing-friendlyPart of University of California Health, which runs 12 hospitalsHome of UCSF Helen Diller Family Comprehensive Cancer Center, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 81% would definitely recommend itOverall rating: 4 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 4.9 (3.79 to 6.02) · 7,590 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 12.8 (11.3 to 14.4) · 2,019 cases, Jan 2024 – Dec 2024Better than the national rate — Death rate among surgical inpatients with serious treatable complications: 139.4 (110.22 to 168.58) · 452 cases, Jul 2022 – Jun 2024Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.622, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.626, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0.491, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.8 (0.7 to 1) · 2,336 cases, Jan 2024 – Dec 2024
See every measure and the patient survey for Alta Bates Summit Medical Center - Alta Bates Camp
Behind the star rating — Deaths: 2 better, 5 the same, 0 worse of 7 measures. Safety: 2 better, 5 the same, 0 worse of 7 measures. Readmissions: 2 better, 6 the same, 1 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.298 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.18 (0.16 to 2.2) · 730 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.87 (0.51 to 1.23) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 188.12 (132.31 to 243.94) · 50 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 6.8 · 50 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10.8 · 41 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.4 · 189 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 12.6 · 184 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.7 · 103 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.9 · 1,585 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.18 (0 to 0.4) · 3,929 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.31 (0.11 to 0.51) · 3,954 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.15 (0.95 to 5.36) · 754 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.62 (0 to 3.33) · 325 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 1.99 (0.39 to 3.59) · 717 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 10.85 (2.27 to 19.44) · 326 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 4.79 (1.08 to 8.49) · 302 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.68 (0.19 to 3.18) · 184 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.17 (0 to 0.88) · 3,240 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.4 · 161 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.207 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.48 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.785 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0 | No different | Oct 2024 – Sep 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.4 · 243 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -58.2 · 194 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -12.3 · 177 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.8 · 209 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.4 (3.8 to 7.5) · 215 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 12.2 (9.4 to 15.5) · 215 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 4.8 · 150 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.2 · 81 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.4 (10 to 18.1) · 315 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.8 (0.6 to 1.2) · 137 cases | No different | Jan 2024 – Dec 2024 |
What patients said (449 patients answered, 15% of those asked)
| Cleanliness | 2 |
| Nurse communication | 2 |
| Doctor communication | 2 |
| Communication about medicines | 2 |
| Discharge information | 2 |
| Overall hospital rating | 2 |
| Quietness | 2 |
| Recommend hospital | 3 |
| Room was "always" clean | 62% |
| Nurses "always" communicated well | 72% |
| Doctors "always" communicated well | 75% |
| Staff "always" explained | 53% |
| Yes, staff "did" give patients this information | 82% |
| Yes, staff "did" give patients information about help after discharge | 82% |
| Doctors "always" explained things so they could understand | 68% |
| Doctors "always" listened carefully | 73% |
| Doctors "always" treated them with courtesy and respect | 83% |
| Patients who gave a rating of "9" or "10" (high) | 58% |
| Staff "always" explained new medications | 67% |
| Nurses "always" explained things so they could understand | 67% |
| Nurses "always" listened carefully | 66% |
| Nurses "always" treated them with courtesy and respect | 81% |
| "Always" quiet at night | 49% |
| "YES", patients would definitely recommend the hospital | 67% |
| Staff "always" explained possible side effects | 38% |
| Yes, staff "did" give patients information about possible symptoms | 83% |
See every measure and the patient survey for UCSF Medical Center
Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 3 better, 5 the same, 3 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 4.9 (3.79 to 6.02) · 7,590 cases | Worse | Jul 2022 – Jun 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 12.8 (11.3 to 14.4) · 2,019 cases | Worse | Jan 2024 – Dec 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 139.4 (110.22 to 168.58) · 452 cases | Better | Jul 2022 – Jun 2024 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.622 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.626 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.491 | Better | Oct 2024 – Sep 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.8 (0.7 to 1) · 2,336 cases | Better | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.24 (0.58 to 1.9) · 4,689 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.05 (0.89 to 1.2) | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.9 · 89 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.5 · 85 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10.1 · 132 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 6.6 · 454 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 618 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.6 · 380 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.7 · 5,000 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.22 (0.06 to 0.38) · 15,965 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.2 (0.05 to 0.35) · 17,859 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 0.85 (0 to 1.83) · 4,184 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2 (1.1 to 2.9) · 6,516 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 7.35 (4.49 to 10.21) · 3,989 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5 (3.22 to 6.77) · 4,087 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.95 (0.74 to 3.15) · 2,034 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.95 (0.63 to 1.28) · 15,431 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4 · 399 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.899 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.689 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.224 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 16 · 156 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20 · 564 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 60.3 · 160 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -9.7 · 550 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 44.1 · 660 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.8 · 667 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.7 (4.8 to 6.7) · 2,019 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6 · 421 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.5 · 53 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20 · 107 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.9 (11.3 to 17.1) · 3,247 cases | No different | Jan 2022 – Dec 2024 |
What patients said (3,181 patients answered, 25% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 71% |
| Nurses "always" communicated well | 80% |
| Doctors "always" communicated well | 80% |
| Staff "always" explained | 61% |
| Yes, staff "did" give patients this information | 88% |
| Yes, staff "did" give patients information about help after discharge | 87% |
| Doctors "always" explained things so they could understand | 74% |
| Doctors "always" listened carefully | 78% |
| Doctors "always" treated them with courtesy and respect | 86% |
| Patients who gave a rating of "9" or "10" (high) | 76% |
| Staff "always" explained new medications | 75% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 78% |
| Nurses "always" treated them with courtesy and respect | 86% |
| "Always" quiet at night | 50% |
| "YES", patients would definitely recommend the hospital | 81% |
| Staff "always" explained possible side effects | 46% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$53,893
Medicare paid this office $53,893 for 437 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| New patient visit (45+ min) | 146 | $16,752 | $115 |
| Return visit (30+ min) | 135 | $12,432 | $86 |
| Short return visit (20+ min) | 180 | $12,371 | $54 |
| Aspiration and/or injection of fluid from large joint | 126 | $9,011 | $47 |
| New patient visit (30+ min) | 13 | $1,000 | $77 |
See all 6 services
| New patient visit (45+ min) | 146 | $16,752 | $115 |
| Return visit (30+ min) | 135 | $12,432 | $86 |
| Short return visit (20+ min) | 180 | $12,371 | $54 |
| Aspiration and/or injection of fluid from large joint | 126 | $9,011 | $47 |
| New patient visit (30+ min) | 13 | $1,000 | $77 |
| Insertion of needle into vein for collection of blood sample | 13 | $112 | $9 |
Procedures Medicare counted
| Hip replacement | 1-10 | None |
Procedures year by year
| Procedure | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Aspiration and/or injection of fluid from large joint | 258 | 143 | 229 | 252 | 212 | 193 |
Times billed to Original Medicare each year. A blank year means fewer than 11 people had it, or none: Medicare does not publish smaller counts. Medicare Advantage patients are not included.
Who their Medicare patients are
437 Original Medicare patients in 2024. Average age 74 · Under 65 8% · 85 and older 10% · Women 68% · Also on Medicaid 26% · Health risk score 1.33. Above the middle of the specialty; the typical physician assistant clinician is at 1.31.
Conditions among them: High blood pressure 59% · Depression 24% · Chronic kidney disease 22% · Cancer 18% · Diabetes 17% · Coronary heart disease 17% · Atrial fibrillation 13% · Heart failure 11% · COPD 11% · Dementia 4% · Stroke 4%.
The office billed $484,448, Medicare allowed $74,569 and paid $53,893; for 758 services of 12 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 437 | 758 | 74 | 1.33 | $484,448 | $53,893 |
| 2023 | 477 | 906 | 74 | 1.13 | $491,183 | $56,266 |
| 2022 | 523 | 1,484 | 74 | 1.12 | $533,891 | $57,323 |
| 2021 | 576 | 1,278 | 73 | 1.13 | $530,525 | $61,846 |
| 2020 | 348 | 676 | 74 | 1.21 | $302,919 | $31,202 |
| 2019 | 613 | 1,212 | 73 | 1.20 | $572,430 | $59,673 |
| 2018 | 542 | 960 | 73 | 1.25 | $503,147 | $51,239 |
| 2017 | 515 | 984 | 73 | 1.20 | $432,976 | $50,144 |
| 2016 | 483 | 885 | 73 | 1.15 | $385,995 | $44,029 |
| 2015 | 311 | 475 | 72 | 1.19 | $200,864 | $21,459 |
| 2014 | 293 | 463 | 72 | 1.12 | $215,239 | $22,521 |
| 2013 | 159 | 305 | 70 | 1.23 | $118,597 | $10,490 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 5 services
| New patient visit (45+ min) | 159 | $16,912 | $106 |
| Short return visit (20+ min) | 229 | $16,137 | $53 |
| Return visit (30+ min) | 135 | $11,161 | $80 |
| Aspiration and/or injection of fluid from large joint | 146 | $9,238 | $44 |
| Insertion of needle into vein for collection of blood sample | 11 | $101 | $8 |
2022: 8 services
| New patient visit (45+ min) | 189 | $18,231 | $96 |
| Short return visit (20+ min) | 212 | $13,649 | $50 |
| Return visit (30+ min) | 134 | $9,853 | $72 |
| Aspiration and/or injection of fluid from large joint | 163 | $8,794 | $35 |
| Short return visit | 53 | $1,621 | $27 |
| New patient visit (30+ min) | 16 | $716 | $45 |
| Injection, methylprednisolone acetate, 80 mg | 25 | $210 | None |
| Injection, ropivacaine hydrochloride, 1 mg | 13 | $6 | None |
2021: 8 services
| New patient visit (45+ min) | 175 | $18,481 | $106 |
| Return visit (30+ min) | 196 | $14,691 | $72 |
| Short return visit (20+ min) | 169 | $9,588 | $50 |
| Aspiration and/or injection of fluid from large joint | 172 | $8,758 | $38 |
| Long return visit (40+ min) | 29 | $2,791 | $90 |
| New patient visit (30+ min) | 35 | $2,349 | $67 |
| Short return visit | 50 | $1,650 | $30 |
| Injection, methylprednisolone acetate, 80 mg | 38 | $340 | None |
2020: 7 services
| Return visit (30+ min) | 113 | $6,369 | $52 |
| Aspiration and/or injection of fluid from large joint | 97 | $5,847 | $41 |
| Long return visit (40+ min) | 63 | $5,079 | $78 |
| Short return visit (20+ min) | 90 | $4,795 | $47 |
| New patient visit (45+ min) | 50 | $4,446 | $89 |
| New patient visit (30+ min) | 42 | $2,689 | $64 |
| Injection, methylprednisolone acetate, 80 mg | 17 | $231 | None |
2019: 7 services
| Return visit (30+ min) | 210 | $13,502 | $55 |
| New patient visit (45+ min) | 136 | $11,674 | $86 |
| Aspiration and/or injection of fluid from large joint | 181 | $10,673 | $41 |
| Long return visit (40+ min) | 109 | $9,411 | $81 |
| Short return visit (20+ min) | 124 | $6,723 | $48 |
| New patient visit (30+ min) | 65 | $4,682 | $72 |
| Injection, methylprednisolone acetate, 80 mg | 26 | $309 | None |
2018: 6 services
| Return visit (30+ min) | 192 | $12,680 | $55 |
| New patient visit (45+ min) | 119 | $10,659 | $90 |
| Aspiration and/or injection of fluid from large joint | 175 | $10,054 | $38 |
| Long return visit (40+ min) | 95 | $7,996 | $82 |
| Short return visit (20+ min) | 126 | $5,638 | $38 |
| New patient visit (30+ min) | 69 | $3,721 | $54 |
2017: 7 services
| Return visit (30+ min) | 180 | $11,861 | $58 |
| Aspiration and/or injection of fluid from large joint | 171 | $11,547 | $39 |
| Short return visit (20+ min) | 197 | $9,380 | $38 |
| New patient visit (45+ min) | 83 | $8,112 | $98 |
| New patient visit (30+ min) | 77 | $4,418 | $57 |
| Long return visit (40+ min) | 46 | $3,887 | $84 |
| Short return visit | 21 | $405 | $18 |
2016: 6 services
| New patient visit (45+ min) | 155 | $13,864 | $89 |
| Aspiration and/or injection of fluid from large joint | 167 | $10,077 | $38 |
| Return visit (30+ min) | 138 | $9,028 | $55 |
| Short return visit (20+ min) | 181 | $7,862 | $36 |
| New patient visit (30+ min) | 47 | $2,569 | $55 |
| Short return visit | 21 | $345 | $16 |
2015: 10 services
| Short return visit (20+ min) | 123 | $5,037 | $36 |
| Aspiration and/or injection of fluid from large joint | 85 | $4,140 | $38 |
| Return visit (30+ min) | 51 | $3,113 | $56 |
| New patient visit (45+ min) | 25 | $2,369 | $95 |
| New patient visit (30+ min) | 41 | $2,324 | $57 |
| New patient visit (45+ min) | 13 | $1,288 | $99 |
| Short return visit (20+ min) | 26 | $1,053 | $39 |
| Short return visit | 32 | $640 | $19 |
| Aspiration and/or injection of fluid from large joint | 15 | $623 | $42 |
| Return visit (30+ min) | 11 | $601 | $55 |
2014: 6 services
| New patient visit (45+ min) | 73 | $6,803 | $93 |
| Aspiration and/or injection of fluid from large joint | 78 | $4,683 | $37 |
| Short return visit (20+ min) | 101 | $4,483 | $37 |
| New patient visit (30+ min) | 61 | $3,402 | $56 |
| Return visit (30+ min) | 40 | $2,288 | $57 |
| Short return visit | 33 | $590 | $17 |
2013: 6 services
| Aspiration and/or injection of fluid from large joint | 56 | $3,755 | $28 |
| Short return visit (20+ min) | 53 | $1,982 | $32 |
| New patient visit (30+ min) | 29 | $1,412 | $49 |
| New patient visit (45+ min) | 14 | $1,348 | $96 |
| Return visit (30+ min) | 22 | $1,202 | $55 |
| Short return visit | 37 | $643 | $16 |
Medicaid work
$0 in 2018
Medicaid paid $0 for 13 billed services this clinician did in 2018, up to 13 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Hospital outpatient clinic visit for assessment and management of a patient | 13 | $0 |
| 2018 | 13 | 1 | 13 | $0 |
Drugs they prescribed that Part D paid
$3,611
Pharmacies billed $3,611 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 31% of their Part D prescriptions (102 of 330) in 2024. Above the middle of the specialty; the typical physician assistant clinician is at 1%.
325 generic and fewer than 11 brand-name prescriptions · $3,611 in drug cost · 11 antibiotic prescriptions.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Oxycodone | 70 | $529 | $8 |
| Meloxicam | 125 | $441 | $4 |
| Celecoxib | 23 | $285 | $12 |
| Hydrocodone-Acetaminophen | 13 | $275 | $21 |
| Gabapentin | 17 | $50 | $3 |
Year by year
| 2024 | 330 | 145 | 31% (102) | None | $3,611 |
| 2023 | 230 | 110 | 31% (72) | None | $2,925 |
| 2022 | 221 | 106 | 29% (64) | 0% | $2,862 |
| 2021 | 272 | 137 | 37% (101) | None | $3,461 |
| 2020 | 325 | 128 | 32% (103) | 4% | $3,933 |
| 2019 | 373 | 163 | 27% (99) | 6% | $8,892 |
| 2018 | 288 | 132 | 30% (85) | 16% | $5,906 |
| 2017 | 258 | 129 | 19% (49) | 21% | $7,983 |
| 2016 | 185 | 93 | 21% (38) | 28% | $7,205 |
| 2015 | 217 | 117 | 30% (65) | 37% | $12,007 |
| 2014 | 181 | 105 | 19% (35) | 35% | $15,607 |
| 2013 | 179 | 104 | 22% (39) | 39% | $14,257 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 5 drugs
| Celecoxib | 12 | $750 | $63 |
| Diclofenac | 28 | $724 | $26 |
| Meloxicam | 72 | $369 | $5 |
| Oxycodone | 46 | $351 | $8 |
| Gabapentin | 15 | $60 | $4 |
2022: 5 drugs
| Celecoxib | 30 | $1,132 | $38 |
| Diclofenac | 32 | $719 | $22 |
| Oxycodone | 48 | $434 | $9 |
| Gabapentin | 39 | $174 | $4 |
| Meloxicam | 33 | $139 | $4 |
2021: 7 drugs
| Diclofenac | 47 | $768 | $16 |
| Oxycodone | 70 | $633 | $9 |
| Celecoxib | 18 | $571 | $32 |
| Oxycodone-Acetaminophen | 11 | $218 | $20 |
| Meloxicam | 44 | $126 | $3 |
| Gabapentin | 27 | $125 | $5 |
| Amoxicillin | 11 | $23 | $2 |
2020: 7 drugs
| Diclofenac | 55 | $1,383 | $25 |
| Oxycodone | 53 | $530 | $10 |
| Celecoxib | 17 | $378 | $22 |
| Meloxicam | 62 | $254 | $4 |
| Hydrocodone-Acetaminophen | 13 | $116 | $9 |
| Gabapentin | 21 | $86 | $4 |
| Tramadol | 26 | $83 | $3 |
2019: 6 drugs
| Diclofenac | 53 | $1,498 | $28 |
| Celecoxib | 21 | $914 | $44 |
| Oxycodone | 65 | $728 | $11 |
| Meloxicam | 89 | $340 | $4 |
| Gabapentin | 52 | $288 | $6 |
| Tramadol | 25 | $113 | $5 |
2018: 7 drugs
| Diclofenac | 41 | $1,511 | $37 |
| Voltaren | 23 | $1,264 | $55 |
| Celecoxib | 31 | $800 | $26 |
| Oxycodone | 36 | $473 | $13 |
| Gabapentin | 33 | $173 | $5 |
| Meloxicam | 40 | $161 | $4 |
| Tramadol | 34 | $160 | $5 |
2017: 6 drugs
| Voltaren | 36 | $1,991 | $55 |
| Celecoxib | 28 | $1,670 | $60 |
| Diclofenac | 43 | $1,379 | $32 |
| Oxycodone | 28 | $504 | $18 |
| Gabapentin | 28 | $328 | $12 |
| Meloxicam | 20 | $58 | $3 |
2016: 6 drugs
| Celecoxib | 35 | $1,953 | $56 |
| Voltaren | 34 | $1,681 | $49 |
| Diclofenac | 22 | $768 | $35 |
| Oxycodone | 24 | $386 | $16 |
| Gabapentin | 20 | $152 | $8 |
| Tramadol | 12 | $50 | $4 |
2015: 6 drugs
| Enoxaparin | 15 | $2,556 | $170 |
| Voltaren | 51 | $2,383 | $47 |
| Celecoxib | 20 | $2,238 | $112 |
| Oxycodone | 39 | $1,151 | $30 |
| Mupirocin | 15 | $238 | $16 |
| Tramadol | 11 | $53 | $5 |
2014: 4 drugs
| Enoxaparin | 36 | $7,310 | $203 |
| Voltaren | 40 | $1,805 | $45 |
| Diclofenac | 14 | $431 | $31 |
| Oxycodone | 12 | $293 | $24 |
2013: 6 drugs
| Celebrex | 20 | $4,800 | $240 |
| Enoxaparin | 18 | $3,885 | $216 |
| Voltaren | 31 | $1,791 | $58 |
| Oxycodone | 19 | $601 | $32 |
| Tramadol | 14 | $104 | $7 |
| Amoxicillin | 17 | $49 | $3 |
Money from drug and device companies
$26 in 2023
| 2023 | 1 | 1 | None | $26 |
| 2022 | 1 | 1 | None | $29 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Medical Device Business Services | Dynatape | $26 | 1 payment
|
See the published payment
| Medical Device Business Services | Meals · 2023-11-01 | Dynatape | $26 |
See earlier years (2022)
2022: $29
| Biohaven Pharmaceutical Holding Company | Nurtec Odt | $29 | 1 payment
|
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 75.0 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1366750424
- Licence
- CA PA17870
- Group
- UCSF Medical Group Business Services · University of California San Francisco
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- Yes
- Taxonomy
- Physician assistant, medical (363AM0700X)
- Mailing address
- 1500 Owens St, Box 3004, San Francisco, CA, 94158
- NPI first listed
- 2010-09-22
- NPI last updated
- 2010-09-22
This is when the NPI record was last certified, not a medical board exam.